You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
A Bioactive Nanofibrous Sewing Cuff for Treatment of Cardiac Valvular Disease
SBC: BIOSURFACES INC Topic: NHLBIPROJECT SUMMARY Cardiac valve repair or replacement is indicated when progression of degenerative disease or bacterial infection of the native valve results in valvular dysfunction, thereby impacting cardiac output. Both procedures require the use of a woven or knitted polyester material with an internal reinforcement (Teflon, silicone or metal) to either stabilize the native valve (annuloplasty r ...
SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
A Compact, High-power Terahertz Amplifier for DNP-NMR and EPR Spectroscopy
SBC: BRIDGE 12 TECHNOLOGIES, INC. Topic: NIGMSDESCRIPTION (provided by applicant): We propose to develop a compact, cost-effective Traveling Wave Tube (TWT) amplifier at 263 GHz with 50 W of peak power, 5 W of continuous wave power and 5% instantaneous bandwidth for application in Dynamic Nuclear Polarization (DNP) enhanced solid-state and solution-state NMR and Electron Paramagnetic Resonance (EPR) spectroscopy. With DNP, the inherently smal ...
SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
ACOUSTOPHORETIC TRANSFUSION TO REDUCE EMBOLIZATION IN CARDIOPULMONARY BYPASS
SBC: Flodesign Sonics, Inc. Topic: NHLBIDESCRIPTION (provided by applicant): Retransfusion of a patient's shed blood during cardiopulmonary bypass is attractive since it reduces the need for allogeneic transfusion, minimizes cost, and decreases transfusion related morbidity. Heterologous transfusions are linked to increased long term mortality after cardiac surgery. However, brain damage after cardiac surgery with retransfusion of ...
SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
A Culture-Free Platform for Rapid Pathogen Identification
SBC: HELIXBIND, INC. Topic: NIAIDDESCRIPTION (provided by applicant): A Culture-Free Platform for Rapid Pathogen Identification Project Summary Sepsis is a one of the leading causes of morbidity and mortality in the US, with more than 751,000 confirmed cases occurring every year and 210,000 mortalities. This high mortality rate (~30%) means that nearly 600 patients a day succumb to sepsis-related infections. In addition to the hu ...
SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Adaptive Optics OCT/Fluorescence Small Animal Imager
SBC: PHYSICAL SCIENCES INC. Topic: NEIDESCRIPTION (provided by applicant): Physical Sciences Inc. proposes to develop a new, integrated multimodal adaptive optics small animal imager, including AO-OCT and AO scanning laser fluorescence (fAOSLO), and to demonstrate its applications to detectingpathology in the retinas of rodent models of eye disease. The imaging platform includes novel design elements such as adaptable wavefront sensin ...
SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Adolescent Screener and Opioid Assessment for Patients with Pain (A-SOAPP)
SBC: Inflexxion, Inc. Topic: NIDADESCRIPTION (provided by applicant): Pain management including the use of opioid analgesics is recommended for adolescents who are suffering from recurrent or chronic pain associated with a specific etiology such as cancer, cystic fibrosis, sickle cell anemia, hemophilia or organ transplants (see citations by etiology in letter of support from CO-I, Dr. Solodiuk). Preventive screening tools provi ...
SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Affordable Cryogen-Free Point-of-Care 1.5 T Extremity MRI
SBC: Superconducting Systems, Inc. Topic: NIAMSAbstract The overall goal of this Fast Track project is to combine innovations in superconducting magnet design and new developments in solid state MRI to create a highly compact, robust, mobile, lightweight, and affordable MRI for scanning the peripheralskeleton, including the knee, of the majority of the public. This scanner will use a unique, cryogen-free 3-bore actively shielded superconducti ...
SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
A Millimeter-wave Tunable Cavity for Ultra-sensitive Solids and Liquids DNP-NMR at Low Budget
SBC: DOTY SCIENTIFIC, INC. Topic: NIA? DESCRIPTION (provided by applicant): NMR is probably the most powerful and widely used analytical technique for structure determination and function elucidation of molecules of all types, but it suffers from low sensitivity, particularly for insoluble biological macromolecules. Dynamic Nuclear Polarization (DNP) with Magic Angle Spinning (MAS) has recently demonstrated S/N gains exceeding t ...
STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
An Adaptive Prosthetic Terminal Device
SBC: EMPIRE ROBOTICS, INC. Topic: NICHDDESCRIPTION (provided by applicant): Empire Robotics, Inc., in collaboration with Liberating Technologies, Inc., is proposing to develop an adaptive prosthetic gripper enabled by the jamming of granular media. Empire Robotics has previously demonstratedthe utility of the gripper's core technology-in which granular media contained in a flexible, impermeable membrane can transition between s ...
SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
A New MicroRNA-1291 Replacement Therapy for Pancreatic Cancer Disease
SBC: MIRNA THERAPEUTICS, INC. Topic: NIAAADESCRIPTION (provided by applicant): Pancreatic cancer is the fourth leading cause of cancer-related death in the United States. There is a clear need for more effective therapies to treat deadly pancreatic cancer disease. MicroRNAs (miRNA or miR) are a large group of short, noncoding RNAs that control posttranscriptional gene expression in human cells, and there is increasing evidence for the exi ...
STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health